Arete Wealth Advisors’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-12,246
| Closed | -$367K | – | 386 |
|
|
2021
Q1 | $367K | Sell |
12,246
-1,690
| -12% | -$50.6K | 0.05% | 288 |
|
|
2020
Q4 | $442K | Buy |
13,936
+200
| +1% | +$6.34K | 0.06% | 250 |
|
|
2020
Q3 | $367K | Hold |
13,736
| – | – | 0.06% | 261 |
|
|
2020
Q2 | $372K | Hold |
13,736
| – | – | 0.06% | 261 |
|
|
2020
Q1 | $268K | Hold |
13,736
| – | – | 0.05% | 255 |
|
|
2019
Q4 | $322K | Buy |
+13,736
| New | +$322K | 0.06% | 284 |
|